DBV Technologies S.A.
Last updated September 27, 2026
Organization details
- Legal name
- DBV Technologies S.A.
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- France
- Headquarters city
- Chatillon
- Headquarters country
- France
- Fiscal year end
- December
- Ticker symbol
- DBVT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001613780
- ISIN
- FR0010417345
Board of directors
-
Adora Ndu · DirectorSince 2024
-
Daniel B. Soland · DirectorSince 2023
-
Daniel Tasse · Director · CHIEF EXECUTIVE OFFICERSince 2023
- Since 2025
- Since 2025
-
Philina Lee · DirectorSince 2025
-
Timothy E. Morris · DirectorSince 2023
Chief executives
Daniel Tasse
· CHIEF EXECUTIVE OFFICER
Dates unknown
Board connections
6 of this board's directors also sit on 17 other boards.
- via Adora Ndu, Daniel B. Soland, Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Timothy E. Morris
- via Daniel Tasse
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $15,511,198
- 7 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | Mohideen Pharis Officer (Chief Medical Officer) | Open-market sale | −464 | $2.70 | $1,253 |
| Jan 29, 2026 | Mohideen Pharis Officer (Chief Medical Officer) | Open-market sale | −534 | $4.86 | $2,595 |
| Dec 18, 2025 | EPIC Bpifrance Member of 10% owner group | Open-market sale | −1,292,103 | $4.19 | $5,413,912 |
| Dec 17, 2025 | EPIC Bpifrance Member of 10% owner group | Open-market sale | −2,036,990 | $4.84 | $9,859,032 |
| Dec 17, 2025 | EPIC Bpifrance Member of 10% owner group | Open-market sale | −40,000 | $5.28 | $211,200 |
| Nov 21, 2025 | Boucinha Virginie Officer (Chief Financial Officer) | Grant or award | +32,000 | — | — |
| Nov 21, 2025 | Trapp Kevin Michael Officer (Chief Commercial Officer) | Grant or award | +55,000 | — | — |
| Nov 21, 2025 | Mohideen Pharis Officer (Chief Medical Officer) | Open-market sale | −1,624 | $2.77 | $4,498 |
| Nov 21, 2025 | Mohideen Pharis Officer (Chief Medical Officer) | Grant or award | +44,000 | — | — |
| Nov 20, 2025 | Mohideen Pharis Officer (Chief Medical Officer) | Open-market sale | −6,496 | $2.88 | $18,708 |
| Jul 29, 2025 | Mohideen Pharis Officer (Chief Medical Officer) | Open-market sale | −464 | $2.22 | $1,030 |
| May 22, 2025 | Mohideen Pharis Officer (Chief Medical Officer) | Open-market sale | −397 | $1.84 | $730 |
| Jan 30, 2025 | Mohideen Pharis Officer (Chief Medical Officer) | Open-market sale | −600 | $0.85 | $510 |
| Nov 25, 2024 | Mohideen Pharis Officer (Chief Medical Officer) | Open-market sale | −565 | $0.57 | $322 |
| Nov 22, 2024 | Mohideen Pharis Officer (Chief Medical Officer) | Open-market sale | −342 | $0.53 | $181 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.